| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.057 | 0.3 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |